Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’-Reference-Cited by-同舟云学术

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

Published:2008-11 Issue:17 Volume:44 Page:2587-2599
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Collette Sandra,Collette Laurence,Budiharto Tom,Horiot Jean-Claude,Poortmans Philip M.,Struikmans Henk,Van den Bogaert Walter,Fourquet Alain,Jager Jos J.,Hoogenraad Willem,Mueller Rolf-Peter,Kurtz John,Morgan David A.L.,Dubois Jean-Bernard,Salamon Emile,Mirimanoff Rene,Bolla Michel,Van der Hulst Marleen,Wárlám-Rodenhuis Carla C.,Bartelink Harry

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer;Fisher;New Engl J Med,2002

2. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer;Veronesi;New Engl J Med,2002

3. Et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial;Van Dongen;J Natl Cancer Inst,2000

4. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis – Danish Breast Cancer Cooperative Group;Blichert-Toft;J Natl Cancer Inst Monogr,1992

5. Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer—Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR);Cancers;2024-05-30

2. Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study;Clinical and Translational Radiation Oncology;2024-05

3. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center;Brachytherapy;2024-05

4. Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy;Journal of Biomedical Optics;2024-04-25

5. Stereotactic Body Radiation Therapy to the Foot for Bone Metastasis;Advances in Radiation Oncology;2024-02